363
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models

, , , , , & show all
Pages 503-512 | Received 26 Nov 2010, Accepted 19 May 2011, Published online: 04 Jul 2011

References

  • Vartiainen E, Laatikainen T, Salomaa V, Jousilahti P, Peltonen M, Puska P. The FINRISK FUNCTION: Estimation of the risk of coronary events and stroke in the Finnish population. SLL. 2007;62:4507–13. Available at: www.fimnet.fi/cgi-cug/brs/artikkeli.cgi?docn=000029286) (in Finnish; abstract and functions in English).
  • Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.
  • Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–478.
  • Holvoet P, Jenny N, Schreiner P, Tracy R, Jacobs D. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2007;194:245–52.
  • Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005;112:651–7.
  • Boutouyrie P, Tropeano I, Asmar R, Gautier I, Benetos A, Lacolley P, . Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study. Hypertension. 2002;39:10–15.
  • Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects > 70 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046–50.
  • Lakka H-M, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J, . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.
  • Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med. 2006;38:64–80.
  • Kullo IJ, Cassidy AE, Peyser PA, Turner ST, Sheedy PF 2nd, Bielak LF. Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults. Am J Cardiol. 2004;94:1554–8.
  • Koskinen J, Kähönen M, Viikari J, Taittonen L, Laitinen T, Rönnemaa T, . Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: The cardiovascular risk in young Finns study. Circulation. 2009;120:229–36.
  • Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care. 2005;28:1769–78.
  • Pohjantähti-Maaroos H, Palomäki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K. Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol. 2010;9:41.
  • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report. Circulation. 2002;106:3143–421.
  • Aittasalo M, Miilunpalo S, Suni J. The effectiveness of physical activity counseling in a work-site setting. A randomized controlled trial. Patient Educ Couns. 2004;55:193–202.
  • Ainsworth B, Haskell W, Whitt M, Irwin M, Swartz A, Strath S, . Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:498–516.
  • Sigurdardottir V, Fagerberg B, Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med. 2002;252:440–7.
  • Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, . The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes. 2004;53:1068–73.
  • Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, . Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473–8.
  • Cohn J, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, . Non-invasive pulse wave analysis for the early detection of vascular disease. Hypertension. 1995;26:503–8.
  • Hae Guen Song, Eung Ju Kim, Hong Seog Seo, Seong Hwan Kim, Chang Gyu Park, Seong Woo Han, . Relative contributions of different cardiovascular risk factors to significant arterial stiffness. Int J Cardiol. 2010;139:263–8.
  • Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, . Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly. Findings from the Health, Aging and Body Composition Study. Arterioscler Thromb Vasc Biol. 2003; 23:1444–8.
  • Ueba T, Nomura S, Nishikawa T, Kajiwara M, Yamashita K. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese. Atherosclerosis. 2009;203:243–8.
  • Ge JY, Li XL, Zhang HF, Xu Q, Tong M, Wang JG. Elasticity indices of large and small arteries in relation to the metabolic syndrome in Chinese. Am J Hypertens. 2008;21:143–7.
  • Fjeldstad A, Fjeldstad C, Acree L, Nickel KJ, Montgomery PS, Comp PC, . The relationship between arterial elasticity and metabolic syndrome features. Angiology. 2007;58:5–10.
  • ; Emerging Risk Factors CollaborationSarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.
  • Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, . Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. Am J Coll Cardiol. 2010;55:2390–8.
  • Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, .; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–414.
  • Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, . Thirty-five year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2010;39:504–18.
  • Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health. 2005;27:93–100.
  • Lapointe A, Couillard C, Piché ME, Weisnagel SJ, Bergeron J, Nadeau A, . Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. Atherosclerosis. 2007;191:362–8.
  • Hamburg NM, Larson MG, Vita JA, Vasan RS, Keyes MJ, Widlansky ME, . Metabolic syndrome, insulin resistance and brachial artery vasodilator function in Framingham offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008;101:82–8.
  • McVeigh GE, Hamilton PK, Morgan DR. Evaluation of mechanical arterial properties: clinical, experimental and therapeutic aspects. Clin Sci (Lond). 2002;102:51–67.
  • Domanski M, Mitchell G, Pfeffer M, Neaton J, Norman J, Svendsen K, . Pulse pressure and cardiovascular disease-related mortality. Follow-up study of multiple risk factor intervention trial (MRFIT). JAMA. 2002;287:2677–83.
  • Franklin S, Khan S, Wong N, Larson M, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354–60.
  • Mulé G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, . Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension. Am J Hypertens. 2007;20:197–203.
  • Ballantyne C, Arroll B, Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J. 2005;26: 2224–31.
  • Van Hateren KJ, Landman GW, Kleefstra N, Logtenberg SJ, Groenier KH, Kamper AM, . The lipid profile and mortality risk in elderly type 2 diabetic patients: A ten-year follow-up study (ZODIAC-13). PLoS One. 2009;4:e8464.
  • Elosua R, Molina L, Fito M, Arquer A, Sanchez-Quesada JL, Covas MI, . Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis. 2003;167:327–34.
  • Leibovitz E, Hazanov N, Zimlichman R, Shargorodsky M, Gavish D. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens. 2001;14:1096–8.
  • Laurent S, Cockroft J, Van Bortel L, Boutoutyrie P, Giannattasio C, Hayoz D, . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.
  • Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL, . Pulse waveform analysis of arterial compliance: relation to other techniques, age, and metabolic variables. Am J Hypertens. 2000;13:1243–9.
  • Wilson AM, O'Neal D, Nelson CL, Prior DL, Best JD, Jenkins AJ. Comparison of arterial assessments in low and high vascular disease groups. Am J Hypertens. 2004;17:285–91.
  • Duprez DA, De Buyzere ML, De Bruyne L, Clement DL, Cohn JN. Small and large arterial elasticity indices in peripheral arterial occlusive disease (PAOD). Vasc Med. 2001; 6:211–4.
  • Li X, Qiong XU, Tong M, Lu X, Zhang H, Zhou Y, . Microalbuminuria associated with systolic blood pressure and arterial compliance in Chinese metabolic syndrome patients. Chin Med J. 2007;120:1395–9.
  • Prisant LM, Loebl DH, Waller JL. Arterial elasticity and erectile dysfunction in hypertensive men. J Clin Hypertens. 2006;8:768–74.
  • Zimlichman R, Shargorodsky M, Boaz M, Duprez D, Rahn KH, Rizzoni D, . Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: reliability, repeatability, and establishment of normal values for healthy European population—the seven European sites study (SESS). Am J Hypertens. 2005;18:65–71.
  • Duprez D, Kaiser D, Whitwam W, Finkelstein S, Belalcazar A, Patterson R, . Determinants of radial artery pulse wave analysis in asymptomatic individuals. Am J Hypertens. 2004;17:647–53.
  • Kressel G, Trunz B, Bub A, Hülsmann O, Wolters M, Lichtinghagen R, . Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis. 2009;202:263–71.
  • Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, . Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30:318–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.